Business Of Biotech cover image

Bacterial Therapy: Modulation of the Microbiome With Dr. Bernat Olle

Business Of Biotech

00:00

The Preemptive Clinical Use of Bacteria Therapeutics

Vedanta is developing a drug to repopulate the gut microbiome with bacteria. The company says it would be safe and oral so patients could take them at home. Vedanta has not seen any severe adverse events or high-grade adverse events that are problematic, they say.

Play episode from 22:37
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app